TILT Holdings (TLLTF) Total Liabilities (2021 - 2025)
TILT Holdings (TLLTF) reported Total Liabilities of $200.7 million for Q2 2025, up 16.01% on a YoY basis from $173.0 million in Q2 2024, and little changed quarter-over-quarter from $200.1 million in Q1 2025.
TILT Holdings (TLLTF) Total Liabilities (2021 - 2025) Analysis & Trends
TILT Holdings has reported Total Liabilities for 5 years, with the latest figure at $200.7 million in Q2 2025.
- For the quarter ending Q2 2025, Total Liabilities rose 16.01% year-over-year to $200.7 million; the trailing twelve-month figure through Jun 2025 stood at $200.7 million (up 16.01% YoY), and the FY2024 full-year result was $188.5 million, up 11.69% from the prior year.
- Total Liabilities for Q2 2025 stood at $200.7 million, roughly flat from $200.1 million in the prior quarter.
- The five-year high for Total Liabilities was $200.7 million in Q2 2025, with the low at -$244.4 million in Q3 2021.
- Historically, Total Liabilities has averaged $104.7 million across 5 years, with a median of $170.6 million in 2022.
- Annual changes were most pronounced in 2022 — Total Liabilities surged 179.69% — and 2023, when it retreated 13.18%.
- TILT Holdings' Total Liabilities stood at $155.7 million in 2021, then gained by 10.78% to $172.5 million in 2022, then decreased by 2.13% to $168.8 million in 2023, then climbed by 11.69% to $188.5 million in 2024, then grew by 6.46% to $200.7 million in 2025.
- The last three Total Liabilities figures came in at $200.7 million (Q2 2025), $200.1 million (Q1 2025), and $188.5 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 31.81 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 11.92 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 813.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 148.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.50 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.72 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.51 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.13 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.82 Bn |
| 10 | TILT Holdings | - | - | 1.82 Mn | 200.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 200.71 Mn |
| Mar 31, 2025 | 200.11 Mn |
| Dec 31, 2024 | 188.53 Mn |
| Sep 30, 2024 | 178.19 Mn |
| Jun 30, 2024 | 173.01 Mn |
| Mar 31, 2024 | 178.99 Mn |
| Dec 31, 2023 | 168.80 Mn |
| Sep 30, 2023 | 167.09 Mn |
| Jun 30, 2023 | 166.87 Mn |
| Mar 31, 2023 | 167.63 Mn |
| Dec 31, 2022 | 172.46 Mn |
| Sep 30, 2022 | 170.56 Mn |
| Jun 30, 2022 | 192.21 Mn |
| Mar 31, 2022 | -215.26 Mn |
| Dec 31, 2021 | 155.68 Mn |
| Sep 30, 2021 | -244.40 Mn |
| Jun 30, 2021 | -241.19 Mn |